6,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one

Catalog No. :
ACYVMI153
CAS No. :
17817-31-1
Molecular Formula :
C15H10O5
Molecular Weight :
270.24

IUPAC Name:6,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one

6,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$278.00Login to see priceInquiryInquiry
1g95%$904.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
IUPAC Name6,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
MDL No.MFCD00016953
Molecular FormulaC15H10O5
Molecular Weight270.24
SMILESO=C1C(C2=CC=C(O)C=C2)=COC3=C1C=C(O)C(O)=C3
InChI KeyGYLUFQJZYAJQDI-UHFFFAOYSA-N
SynonymUNII-PLM2K574GE | CS-0032293 | XD161696 | 4',6,7-trihydroxy isoflavone | XD161701 | LMPK12050102 | 4'',6,7,-trihydroxyisoflavone | 4',6,7,-Trihydroxyisoflavone | Q23055293 | BDBM50222303 | 6,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-one | Demethyltexasin
CAS No.17817-31-1
PubChem CID5284649

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYVMI153 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFSAR143 route compound structure diagram
    ACFSAR143486-66-8 In Stock
  2. Then
  3. ACYVMI153 route product structure diagram
    ACYVMI15317817-31-1
Inquiry

2. ACYVMI153 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Plus
  5. ACFSAR143 route compound structure diagram
    ACFSAR143486-66-8 In Stock
  6. Then
  7. ACYVMI153 route product structure diagram
    ACYVMI15317817-31-1
Inquiry

Comments (0)